This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Device | FoundationOne Liquid CDx |
Generic Name | Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System |
Applicant | Foundation Medicine Inc.150 Second Streetcambridge, MA 02141 PMA NumberP190032 Supplement NumberS003 Date Received10/28/2021 Decision Date05/25/2022 Product Code PQP Advisory Committee Pathology Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No |
Date Received | 2021-10-28 |
Decision Date | 2022-05-25 |
PMA | P190032 |
Supplement | S003 |
Product Code | PQP |
Advisory Committee | Pathology |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | Foundation Medicine Inc. 150 Second Street cambridge, MA 02141 PMA NumberP190032 Supplement NumberS003 Date Received10/28/2021 Decision Date05/25/2022 Product Code PQP Advisory Committee Pathology Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No Combination ProductNo Approval Order Statement Approval For Updating Of Dual Index Barcode (DIB) Primer From DIBv1 To DIBv2 For F1L CDx Device. |
Supplement Number | Date | Supplement Type |
---|---|---|
P190032 | Original Filing | |
S008 | 2022-09-26 | Real-time Process |
S007 | 2022-08-29 | Special (immediate Track) |
S006 | 2022-08-22 | Special (immediate Track) |
S005 | ||
S004 | ||
S003 | 2021-10-28 | Normal 180 Day Track |
S002 | ||
S001 | 2020-08-28 | Panel Track |